Therapeutic potential of agmatine in the experimental autoimmune encephalomyelitis

Ivana Stevanović; Milica Ninković; Jelena Stanojević; Bojana Mančić; Ivana Stojanović

doi:10.2298/VSP190707145S

Ivana Stevanović University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Milica Ninković University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Jelena Stanojević University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Bojana Mančić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Ivana Stojanović University of Niš, Faculty of Medicine, Institute for Biochemistry, Niš, Serbia

DOI: https://doi.org/10.2298/VSP190707145S

Keywords: agmatine, antioxidants, encephalomyelitis, multiple sclerosis, neuroprotective agents, oxidative stress, rats, treatment

Abstract

Background/Aim. Experimental autoimmune encephalomyelitis (EAE) is a model of multiple sclerosis (MS), in which we investigated the neuroprotective effect of agmatine (AGM), known as a primary amine produced via the decarboxylation of L-arginine. Methods. Dark Agouti rats were divided into groups: control (C), Complete Freund`s Adjuvant (CFA), EAE rats decapitated on the 13th day post immunization (dpi) (EAE13) and on the 20th dpi (EAE20), EAE animals given three (EAE+AGM13) and 10 (EAE+AGM20) doses of AGM, and healthy animals administered three/10 doses of AGM (AGM). Thiobarbituric acid-reacting substances (TBARS), SH groups (SH), total glutathione (GSH), glutathione peroxidase activity (GPx), superoxide dismutase activities (tSOD, MnSOD, CuZnSOD) and nitrite/nitrate concentration (NO₂+NO₃) were assessed in plasma and brain structures [whole encephalitic mass (WEM) and brainstem (BS)]. Results. The obtained results showed that AGM treatment successfully attenuated severe clinical deficits in EAE. Applications of AGM in EAE rats induced normalized TBARS, SH, GSH, GPx and NO in WEM. In BS, AGM expressed less prominent effects, inducing normalized TBARS, GPx and NO, but no effect on SH and GSH. In both brain structures, tSOD activity lowered and normalized at the peak and in the remission phase of the disease, post-AGM treatment. The effect of AGM on the MnSOD in EAE was expressed in WEM/BS only in the remission phase as a reduced activity. Conclusion. Milder clinical form of developed EAE in rats indicates promising therapeutic effect of AGM in MS. The activated antioxidant system and suppressed oxidative/nitrosative stress development may denote a successful blockade of neuroinflammation initiated by EAE immunization. The study implies the capability of AGM to attenuate oxidative/nitrosative damage at the peak of EAE by modulating antioxidative defense capacity during the time-course of the disease. Thus, AGM may be considered as an agent with a beneficial effect on neuroinflammation in EAE.

References

Toader LE, Rosu GC, Catalin B, Tudorica V, Pirici I, Taisescu O, et al. clinical and histopathological assessment on an ani-mal model with experimental autoimmune encephalomyelitis. Curr Health Sci J 2018; 44(3): 280-287.

Miller SD, Karpus WJ. Experimental autoimmune encephalo-myelitis in the mouse. Curr Protoc Immunol 2007; Chapter 15: Unit 15.1.

Lavrnja I, Savic D, Bjelobaba I, Dacic S, Bozic I, Parabucki A, et al. The effect of ribavirin on reactive astrogliosis in experi-mental autoimmune encephalomyelitis. J Pharmacol Sci 2012; 119(3): 221−32.

Robinson A, Harp CT, Noronha A, Miler SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 2014; 122: 173−89.

Ghafourifar P, Mousavizadeh K, Parihar MS, Nazarewicz RR, Pa-rihar A, Zenebe WJ. Mitochondria in multiple sclerosis. Front Biosci 2008; 13: 3116−26.

Smith ME. Phagocytic properties of microglia in vitro: impli-cations for a role in multiple sclerosis and EAE. Microsc Res Tech 2001; 54(2): 81−94.

Cobb CA, Cole MP. Oxidative and nitrative stress in neuro-degeneration. Neurobiol Dis 2015; 84: 4−21.

Lan M, Tang X, Zhang J, Yao Z. Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dys-function of oligodendrocytes. Rev Neurosci 2018; 29(1): 39−53.

Moncada S, Bolaños JP. Nitric oxide, cell bioenergetics and neu-rodegeneration. J Neurochem 2006; 97(6): 1676−89.

Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regula-tion of the expression of inducible nitric oxide synthase. Ni-tric Oxide 2010; 23(2): 75−93.

Ljubisavljevic S, Stojanovic I, Pavlovic D, Milojkovic M, Vojinovic S, Sokolovic D, et al. Correlation of nitric oxide levels in the cere-bellum and spinal cord of experimental autoimmune encepha-lomyelitis rats with clinical symptoms. Acta Neurobiol Exp (Wars) 2012; 72(1): 33−9.

Dimitrijević M, Kotur-Stevuljević J, Stojić-Vukanić Z, Vujnović I, Pilipović I, Nacka-Aleksić M, et al. Sex difference in oxidative stress parameters in spinal cord of rats with experimental au-toimmune encephalomyelitis: relation to neurological deficit. Neurochem Res 2017; 42(2): 481−92.

Stefanović A, Kotur-Stevuljević J, Spasić S, Vekic J, Bujisić N. Asso-ciation of oxidative stress and paraoxonase status with PRO-CAM risk score. Clin Biochem 2009; 42(7−8): 617−23.

Dringen R. Oxidative and antioxidative potential of brain mi-croglial cells. Antioxid Redox Signal 2005; 7 (9-10): 1223−33.

Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59(5): 1609−23.

Regunathan S, Youngson C, Raasch W, Wang H, Reis DJ. Imidaz-oline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J Pharmacol Exp Ther 1996; 276(3): 1272−82.

Chai J, Luo L, Hou F, Fan X, Yu J, Ma W, et al. Agmatine re-duces lipopolysaccharide-mediated oxidant response via acti-vating PI3K/Akt pathway and up-regulating Nrf2 and HO-1 expression in macrophages. PLoS One 2016; 11(9): e0163634.

Stevanovic I, Ninkovic M, Stojanovic I, Ljubisavljevic S, Stojnev S, Bokonjic D. Beneficial effect of agmatine in the acute phase of experimental autoimmune encephalomyelitis in iNOS-/- knockout mice. Chem Biol Interact 2013; 206(2): 309−18.

Hammer LA, Zagon IS, McLaughlin PJ. Improved clinical be-havior of established relapsing-remitting experimental auto-immune encephalomyelitis following treatment with endoge-nous opioids: Implications for the treatment of multiple scle-rosis. Brain Res Bull 2015; 112: 42−51.

Gurd JW, Jones LR, Mahler HR, Moore WJ. Isolation and par-tial characterization of rat brain synaptic membrane. J Neuro-chem 1974; 22(2): 281−90.

Lowry OH, Rosenbrongh NJ, Farr AL, Randal RJ. Protein meas-urement with the folin phenol reagent. J Biol Chem 1951; 193(1): 265−75.

Girotti M, Khan N, Lellan B. Early measurement of systemic li-pid peroxidation products in the plasma of major blunt trau-ma patients. J Trauma 1991; 31(1): 32−5.

Elman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82(1): 70−7.

Anderson ME. The DTNB-GSSG reductase recycling assay for total glutathione (GSH + 1/2GSSG). In: Greenwald RA, edi-tor. Tissue glutathione. Boca Raton: CRC Press; 1996. p. 317−23.

Todorova K, Ivanov S, Genova M. Selenium and glutathion perox-idase enzyme levels in diabetic patients with early spontaneous abortions. Akush Ginekol (Sofiia) 2006; 45(5): 3−9.

Sun M, Zigman S. An important spectrophotometric assay for superoxide dismutase based on epinephrine auto-oxidation. Analyt Biochem 1978; 90: 81−9.

Navarro- Gonzálvez JA, Garcia-Benayas C, Arenas J. Semiauto-mated measurement of nitrate in biological fluids. Clin Chem 1998; 44(3): 679−81.

Kim JH, Yenari MA, Giffard RG, Cho SW, Park KA, Lee JE. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from is-chemia-like injury. Exp Neurol 2004; 189(1): 122−30.

de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacol 2012; 62(7): 2299−308.

Ohl K, Tenbrock K, Kipp M. Oxidative stress in multiple sclero-sis: Central and peripheral mode of action. Exp Neurol 2016; 277: 58−67.

Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, et al. Oxidative damage in multiple sclerosis lesions. Brain 2011; 134(Pt 7): 1914−24.

Ding M, Wong JL, Rogers NE, Ignarro LJ, Voskuhl RR. Gender differences of inducible nitric oxide production in SJL/J mice with experimental autoimmune encephalomyelitis. J Neuro-immunol 1997; 77(1): 99−106.

Halaris A, Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007; 21(11): 885−900.

Calabrese V, Scapagnini G, Ravagna A, Bella R, Butterfield DA, Calvani M, et al. Disruption of thiol homeostasis and nitrosa-tive stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetyl-carnitine. Neurochem Res 2003; 28(9): 1321−8.

Heales SJ, Davies SE, Bates TE, Clark JB. Depletion of brain glutathione is accompanied by impaired mitochondrial func-tion and decreased N-acetyl aspartate concentration. Neuro-chem Res 1995; 20(1): 31−8.

Cross AH, Manning PT, Stern MK, Misko TP. Evidence for the production of peroxynitrite in inflammatory CNS demye-lination. J Neuroimmunol 1997; 80(1−2): 121−30.

Ozgüneş H, Gürer H, Tuncer S. Correlation between plasma malondialdehyde and ceruloplasmin activity values in rheuma-toidarthritis. Clin Biochem 1995; 28(2): 193−4.

Abdul-Aziz KK, Tuorkey MJ. Argon laser phototherapy could eliminate the damage effects induced by the ionizing radiation "gamma radiation" in irradiated rabbits. J Photochem Photo-biol B 2010; 99(1): 29−35.

Lopert P, Patel M. Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption. Redox Biol 2014; 2: 667−72.

Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985; 240(2): 500−8.

Packialakshmi B, Zhou X. Experimental autoimmune encepha-lomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex. PLoS One 2018; 13(4): e0196277.

Souza PS, Gonçalves ED, Pedroso GS, Farias HR, Junqueira SC, Marcon R, et al. Physical exercise attenuates experimental au-toimmune encephalomyelitis by inhibiting peripheral immune response and blood-brain barrier disruption. Mol Neurobiol 2017; 54(6): 4723−37.

Henderson AP, Barnett MH, Parratt JD, Prineas JW. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 2009; 66(6): 739−53.

Williams A, Piaton G, Lubetzki C. Astrocytes-friends or foes in multiple sclerosis? Glia 2007; 55(13): 1300−12.

Michaelis M, Michaelis R, Suhan T, Schmidt H, Mohamed A, Doerr HW, et al. Ribavirin inhibits angiogenesis by tetrahydrobiop-terin depletion. FASEB J 2007; 21(1): 81−7.

Kim S, Moon C, Wie MB, Kim H, Tanuma N, Matsumoto Y, Shin T. Enhanced expression of constitutive and inducible forms of nitric oxide synthase in autoimmune encephalomyelitis. J Vet Sci 2000; 1(1): 11−7.

Auguet M, Viossat I, Marin JG, Chabrier PE. Selective inhibi-tion of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 1995; 69(3): 285−7.

Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpció Boronat M, Trullas R, et al. Protection by imidaz-ol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 1999; 127(6): 1317−26.

Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 2000; 97(19): 10584−9.